16 instalments
The Purity Question
A fourteen-part investigation into what a purity percentage means, who produces it, and why two laboratories analysing the same vial can both be right.
Investigations
Twelve multi-part investigations, each running across issues with numbered instalments. A series is opened when a question turns out to need more than one piece, and it is closed when it is answered or when we run out of ways to ask.
11 instalments
Cold Chain
What actually happens to a peptide between a warehouse in Guangdong and a refrigerator in Leeds.
9 instalments
What a COA Cannot Tell You
Nine things a certificate of analysis is silent about, and what it would cost to find them out.
12 instalments
Twenty Vendors, Twenty Vials
The Journal buys one vial from each of the twenty companies whose names appear most often on the label, and submits every one to independent analysis.
0 instalments
After the Shortage
A shortage declaration created an industry. Its removal is dismantling one.
0 instalments
The Cost Stack
Every dollar between a kilogram of protected amino acid and a monthly prescription, itemised.
8 instalments
The Identity Problem
A mass that matches is not a sequence that is confirmed. Eight instalments on the gap.
12 instalments
The First Twelve Weeks
One instalment for each week of a standard escalation, reported against the trial data and the clinic.
8 instalments
The Stopping Question
Withdrawal trials, maintenance data, and what happens to people who cannot keep paying.
8 instalments
Four Laboratories
Janoshik, Medutest, PeptideMeter and VendorInvestigate, examined as institutions.
0 instalments
The Paper Trail
Ten attempts to trace a vial back to the reactor that produced its contents.
0 instalments
The Price of Access
Eleven countries, eleven answers to the same question: can an ordinary person get this drug, and what does it cost them?